Clinical Trial Update: Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma

View source ↗

Summary

A Johns Hopkins-led trial is exploring personalized biomarkers during neoadjuvant radiation therapy for chordoma at spinal and sacral sites to tailor treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Chordoma of Spine, Chordoma of Skull Base | Status: RECRUITING